A Covid-19 isolation center is prepared as a precautionary measure due to the Omicron variant at the Commonwealth Games Village Sports Complex in New Delhi, India. (Photographer: T. Narayan/Bloomberg)
4 years ago
Dec 28, 2021
Follow the latest updates on the coronavirus pandemic and vaccination numbers in India here.
Senior citizens with co-morbidities, for whom booster doses will be available starting Jan. 10, will not be required to submit any certificate from the doctor at the time of administration of precaution dose, ANI reported citing the Health Ministry.
It added that all personnel on election duty in poll-bound states will also be included in the category of frontline workers.
Delhi Chief Minister Arvind Kejriwal said fresh curbs will be imposed as positivity rate in the state for coronavirus has been above 0.5% for the last two to three days.
A yellow alert has been issued according to the Graded Action Plan and fresh curbs will be imposed. A detailed order on the restrictions will be issued soon, Kejriwal said.
The government has given three approvals in a single day for Corbevax vaccine, Covovax vaccine and anti-viral drug Molnupiravir, Mansukh Mandaviya minister of health and family welfare Tweeted. Approval applicable for restricted use in emergency situation.
Corbevax is India's first indigeneously developed Receptor-Binding Domain protein sub-unit vaccine against Covid-19, made by Biological-E.
The Nanoparticle Vaccine, Covovax, will be manufactured by Pune-based firm Serum Institute of India.
Molnupiravir will be manufactured by 13 companies for restricted use under emergency situation.
